Modulatory mechanisms of cannabinoids as a window of hope to patients with sleep-related cardiometabolic risk

Biomed Pharmacother. 2023 Dec:168:115721. doi: 10.1016/j.biopha.2023.115721. Epub 2023 Oct 16.

Author

Miguel Meira E Cruz¹

Affiliation

¹ Sleep Unit, Centro Cardiovascular da Universidade de Lisboa, Lisbon School of Medicine, Lisbon, Portugal; Centro Europeu do Sono, Lisbon, Portugal. Electronic address: mcruz@medicina.ulisboa.pt.

PMID: 37852101
DOI: 10.1016/j.biopha.2023.115721

No abstract available

Publication types

Letter

MeSH terms

Cannabinoids* / pharmacology
Cannabinoids* / therapeutic use
Cardiovascular Diseases* / drug therapy
Humans
Risk
Sleep

Substances

Cannabinoids